Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front Med    2013, Vol. 7 Issue (2) : 147-149    https://doi.org/10.1007/s11684-013-0274-2
EDITORIAL
Molecular classification and molecular targeted therapy of cancer
Miao Xu(), Jianyong Shao, Yixin Zeng
Department of Research and Molecular Diagnostics, Sun Yat-sen University Cancer Center, the State Key Laboratory of Oncology in South China, Guangzhou 510060, China
 Download: PDF(70 KB)   HTML
 Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Corresponding Author(s): Xu Miao,Email:xumiao@sysucc.org.cn   
Issue Date: 05 June 2013
 Cite this article:   
Yixin Zeng,Miao Xu,Jianyong Shao. Molecular classification and molecular targeted therapy of cancer[J]. Front Med, 2013, 7(2): 147-149.
 URL:  
https://academic.hep.com.cn/fmd/EN/10.1007/s11684-013-0274-2
https://academic.hep.com.cn/fmd/EN/Y2013/V7/I2/147
1 Wang HY, Sun BY, Zhu ZH, Chang ET, To KF, Hwang JS, Jiang H, Kam MK, Chen G, Cheah SL, Lee M, Liu ZW, Chen J, Zhang JX, Zhang HZ, He JH, Chen FL, Zhu XD, Huang MY, Liao DZ, Fu J, Shao Q, Cai MB, Du ZM, Yan LX, Hu CF, Ng HK, Wee JT, Qian CN, Liu Q, Ernberg I, Ye W, Adami HO, Chan AT, Zeng YX, Shao JY. Eight-signature classifier for prediction of nasopharyngeal [corrected] carcinoma survival. J Clin Oncol 2011; 29(34): 4516–4525
doi: 10.1200/JCO.2010.33.7741 pmid:22025164
2 Liang Y, Zhong Z, Huang Y, Deng W, Cao J, Tsao G, Liu Q, Pei D, Kang T, Zeng YX. Stem-like cancer cells are inducible by increasing genomic instability in cancer cells. J Biol Chem 2010; 285(7): 4931–4940
doi: 10.1074/jbc.M109.048397 pmid:20007324
3 Liang Y, Zhang H, Feng QS, Cai MB, Deng W, Qin D, Yun JP, Tsao GS, Kang T, Esteban MA, Pei D, Zeng YX. The propensity for tumorigenesis in human induced pluripotent stem cells is related with genomic instability. Chin J Cancer 2013; 32(4): 205–212
doi: 10.5732/cjc.012.10065 pmid:22704487
4 Guo C, Pan ZG, Li DJ, Yun JP, Zheng MZ, Hu ZY, Cheng LZ, Zeng YX. The expression of p63 is associated with the differential stage in nasopharyngeal carcinoma and EBV infection. J Transl Med 2006; 4(1): 23–30
doi: 10.1186/1479-5876-4-23 pmid:16729897
5 Pan ZG, Kashuba VI, Liu XQ, Shao JY, Zhang RH, Jiang JH, Guo C, Zabarovsky E, Ernberg I, Zeng YX. High frequency somatic mutations in RASSF1A in nasopharyngeal carcinoma. Cancer Biol Ther 2005; 4(10): 1116–1122
doi: 10.4161/cbt.4.10.2023 pmid:16096369
6 Liu X, Lv XB, Wang XP, Sang Y, Xu S, Hu K, Wu M, Liang Y, Liu P, Tang J, Lu WH, Feng QS, Chen LZ, Qian CN, Bei JX, Kang T, Zeng YX. MiR-138 suppressed nasopharyngeal carcinoma growth and tumorigenesis by targeting the CCND1 oncogene. Cell Cycle 2012; 11(13): 2495–2506
doi: 10.4161/cc.20898 pmid:22739938
7 Li YH, Hu CF, Shao Q, Huang MY, Hou JH, Xie D, Zeng YX, Shao JY. Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma. J Transl Med 2008; 6(1): 1–11
doi: 10.1186/1479-5876-6-1 pmid:18171482
8 Cai MB, Wang XP, Zhang JX, Han HQ, Liu CC, Bei JX, Peng RJ, Liang Y, Feng QS, Wang HY, Chen LZ, Fu S, Kang T, Shao JY, Zeng YX. Expression of heat shock protein 70 in nasopharyngeal carcinomas: different expression patterns correlate with distinct clinical prognosis. J Transl Med 2012; 10(1): 96–107
doi: 10.1186/1479-5876-10-96 pmid:22591702
9 Cai MB, Han HQ, Bei JX, Liu CC, Lei JJ, Cui Q, Feng QS, Wang HY, Zhang JX, Liang Y, Chen LZ, Kang TB, Shao JY, Zeng YX. Expression of human leukocyte antigen G is associated with prognosis in nasopharyngeal carcinoma. Int J Biol Sci 2012; 8(6): 891–900
doi: 10.7150/ijbs.4383 pmid:22745579
10 Li J, Qian CN, Zeng YX. Regulatory T cells and EBV associated malignancies. Int Immunopharmacol 2009; 9(5): 590–592
doi: 10.1016/j.intimp.2009.01.015 pmid:19539572
11 Li J, Zhang XS, Xie D, Deng HX, Gao YF, Chen QY, Huang WL, Masucci MG, Zeng YX. Expression of immune-related molecules in primary EBV-positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression. Cancer Biol Ther 2007; 6(12): 1997–2004
doi: 10.4161/cbt.6.12.5160 pmid:18087217
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed